Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SR One Capital Management is a biotechnology venture capital firm founded over a decade ago, with offices in Redwood City, California, and London, United Kingdom. The firm partners with founders and entrepreneurs to translate innovative science into medicines, focusing on companies with strong underlying fundamentals and clearly defined development pathways. SR One aims to support the development of novel approaches to addressing diseases.
Currently, SR One manages a diverse portfolio of investments across various stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C. The firm has established a transatlantic presence, allowing it to access high-quality science and opportunities across North America and Europe. Notable milestones include investments in companies developing therapeutics for a range of diseases, showcasing SR One's commitment to advancing healthcare solutions.
SR One Capital Management invests primarily in biotechnology companies, targeting sectors such as cardiometabolic diseases, oncology, immunology, infectious disease, rare diseases, renal, and neuropsychiatry. The firm employs a back-and-build investment strategy, which allows it to support companies at various stages of development, from clinical to preclinical. This approach enables SR One to provide entrepreneurs with access to essential human, intellectual, and financial resources.
The firm seeks to partner with companies that demonstrate strong fundamentals and clear development pathways. SR One's transatlantic presence enhances its ability to identify high-quality science and investment opportunities across geographies, making it a valuable partner for biotech entrepreneurs aiming to innovate in the healthcare sector.
SR One Capital Management's portfolio includes a range of notable companies focused on advancing healthcare solutions:
Simeon George, MD: CEO & Managing Partner, with a background in leading investments in biotechnology and extensive experience in the life sciences sector.
Rajeev Dadoo, PhD: COO & Managing Partner, specializing in operational management and strategic development within biotech companies.
Jill Carroll: Partner, known for her expertise in investment strategies and portfolio management.
Jake Nunn: Partner, with a focus on identifying and supporting innovative biotech ventures.
Philip Habib: Head of Capital Partnering, responsible for building relationships with potential partners and investors.
Sasha Keough: General Counsel & Chief Compliance Officer, ensuring legal and regulatory compliance across investments.
James Macadam: Chief Financial Officer, overseeing financial operations and strategy for the firm.
Submit your pitch through their website contact form at [URL] or email [address] with your deck for consideration.
What are SR One's investment criteria?
SR One invests in biotechnology companies with strong fundamentals and clear development pathways. They focus on sectors such as cardiometabolic diseases, oncology, immunology, and neuropsychiatry.
How can I apply or pitch to SR One?
Founders can reach out via email to initiate discussions. A well-prepared pitch deck that outlines the company's vision, market opportunity, and development strategy is essential.
What makes SR One different from other venture capital firms?
SR One's transatlantic presence allows it to access high-quality science and investment opportunities across North America and Europe, enhancing its ability to support biotech companies.
What is the geographic scope of SR One's investments?
SR One primarily invests in North America and Europe, leveraging its offices in Redwood City, California, and London, United Kingdom.
What is SR One's approach to post-investment involvement?
SR One provides operational support, mentorship, and access to its extensive network to help portfolio companies navigate challenges and achieve their goals.
What is the typical check size for SR One's investments?
SR One invests across various stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C, with check sizes varying based on the stage and needs of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.